Sites of action of ghrelin receptor ligands in cardiovascular control

Brid Callaghan, Billie Hunne, Haruko Ogawa, Daniela M. Sartor, Trung V. Nguyen, Fe C. Abogadie, Dorota Ferens, Peter McIntyre, Kung Ban, Jonathan Baell, John B. Furness, James A. Brock

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Circulating ghrelin reduces blood pressure, but the mechanism for this action is unknown. This study investigated whether ghrelin has direct vasodilator effects mediated through the growth hormone secreta-gogue receptor 1a (GHSR1a) and whether ghrelin reduces sympathetic nerve activity. Mice expressing enhanced green fluorescent protein under control of the promoter for growth hormone secreta-gogue receptor (GHSR) and RT-PCR were used to locate sites of receptor expression. Effects of ghrelin and the nonpeptide GHSR1a agonist capromorelin on rat arteries and on transmission in sympathetic ganglia were measured in vitro. In addition, rat blood pressure and sympathetic nerve activity responses to ghrelin were determined in vivo. In reporter mice, expression of GHSR was revealed at sites where it has been previously demonstrated (hypothalamic neurons, renal tubules, sympathetic preganglionic neurons) but not in any artery studied, including mesenteric, cerebral, and coronary arteries. In rat, RT-PCR detected GHSR1a mRNA expression in spinal cord and kidney but not in the aorta or in mesenteric arteries. Moreover, the aorta and mesenteric arteries from rats were not dilated by ghrelin or capromorelin at concentrations > 100 times their EC50 determined in cells transfected with human or rat GHSR1a. These agonists did not affect transmission from preganglionic sympathetic neurons that express GHSR1a. Intravenous application of ghrelin lowered blood pressure and decreased splanchnic nerve activity. It is concluded that the blood pressure reduction to ghrelin occurs concomitantly with a decrease in sympathetic nerve activity and is not caused by direct actions on blood vessels or by inhibition of transmission in sympathetic ganglia.

Original languageEnglish
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume303
Issue number8
DOIs
Publication statusPublished - Oct 15 2012

Fingerprint

Ghrelin Receptor
Ghrelin
Growth Hormone
Ligands
Mesenteric Arteries
Blood Pressure
Sympathetic Ganglia
Neurons
Aorta
Arteries
Splanchnic Nerves
Kidney
Polymerase Chain Reaction
Cerebral Arteries
Vasodilator Agents
Blood Vessels
Spinal Cord
Coronary Vessels
Messenger RNA

Keywords

  • Arterial control
  • Blood pressure
  • Sympathetic ganglia

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Sites of action of ghrelin receptor ligands in cardiovascular control. / Callaghan, Brid; Hunne, Billie; Ogawa, Haruko; Sartor, Daniela M.; Nguyen, Trung V.; Abogadie, Fe C.; Ferens, Dorota; McIntyre, Peter; Ban, Kung; Baell, Jonathan; Furness, John B.; Brock, James A.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 303, No. 8, 15.10.2012.

Research output: Contribution to journalArticle

Callaghan, B, Hunne, B, Ogawa, H, Sartor, DM, Nguyen, TV, Abogadie, FC, Ferens, D, McIntyre, P, Ban, K, Baell, J, Furness, JB & Brock, JA 2012, 'Sites of action of ghrelin receptor ligands in cardiovascular control', American Journal of Physiology - Heart and Circulatory Physiology, vol. 303, no. 8. https://doi.org/10.1152/ajpheart.00418.2012
Callaghan, Brid ; Hunne, Billie ; Ogawa, Haruko ; Sartor, Daniela M. ; Nguyen, Trung V. ; Abogadie, Fe C. ; Ferens, Dorota ; McIntyre, Peter ; Ban, Kung ; Baell, Jonathan ; Furness, John B. ; Brock, James A. / Sites of action of ghrelin receptor ligands in cardiovascular control. In: American Journal of Physiology - Heart and Circulatory Physiology. 2012 ; Vol. 303, No. 8.
@article{de064ae17eb44b058a83d7b97feb89db,
title = "Sites of action of ghrelin receptor ligands in cardiovascular control",
abstract = "Circulating ghrelin reduces blood pressure, but the mechanism for this action is unknown. This study investigated whether ghrelin has direct vasodilator effects mediated through the growth hormone secreta-gogue receptor 1a (GHSR1a) and whether ghrelin reduces sympathetic nerve activity. Mice expressing enhanced green fluorescent protein under control of the promoter for growth hormone secreta-gogue receptor (GHSR) and RT-PCR were used to locate sites of receptor expression. Effects of ghrelin and the nonpeptide GHSR1a agonist capromorelin on rat arteries and on transmission in sympathetic ganglia were measured in vitro. In addition, rat blood pressure and sympathetic nerve activity responses to ghrelin were determined in vivo. In reporter mice, expression of GHSR was revealed at sites where it has been previously demonstrated (hypothalamic neurons, renal tubules, sympathetic preganglionic neurons) but not in any artery studied, including mesenteric, cerebral, and coronary arteries. In rat, RT-PCR detected GHSR1a mRNA expression in spinal cord and kidney but not in the aorta or in mesenteric arteries. Moreover, the aorta and mesenteric arteries from rats were not dilated by ghrelin or capromorelin at concentrations > 100 times their EC50 determined in cells transfected with human or rat GHSR1a. These agonists did not affect transmission from preganglionic sympathetic neurons that express GHSR1a. Intravenous application of ghrelin lowered blood pressure and decreased splanchnic nerve activity. It is concluded that the blood pressure reduction to ghrelin occurs concomitantly with a decrease in sympathetic nerve activity and is not caused by direct actions on blood vessels or by inhibition of transmission in sympathetic ganglia.",
keywords = "Arterial control, Blood pressure, Sympathetic ganglia",
author = "Brid Callaghan and Billie Hunne and Haruko Ogawa and Sartor, {Daniela M.} and Nguyen, {Trung V.} and Abogadie, {Fe C.} and Dorota Ferens and Peter McIntyre and Kung Ban and Jonathan Baell and Furness, {John B.} and Brock, {James A.}",
year = "2012",
month = "10",
day = "15",
doi = "10.1152/ajpheart.00418.2012",
language = "English",
volume = "303",
journal = "American Journal of Physiology",
issn = "0002-9513",
publisher = "American Physiological Society",
number = "8",

}

TY - JOUR

T1 - Sites of action of ghrelin receptor ligands in cardiovascular control

AU - Callaghan, Brid

AU - Hunne, Billie

AU - Ogawa, Haruko

AU - Sartor, Daniela M.

AU - Nguyen, Trung V.

AU - Abogadie, Fe C.

AU - Ferens, Dorota

AU - McIntyre, Peter

AU - Ban, Kung

AU - Baell, Jonathan

AU - Furness, John B.

AU - Brock, James A.

PY - 2012/10/15

Y1 - 2012/10/15

N2 - Circulating ghrelin reduces blood pressure, but the mechanism for this action is unknown. This study investigated whether ghrelin has direct vasodilator effects mediated through the growth hormone secreta-gogue receptor 1a (GHSR1a) and whether ghrelin reduces sympathetic nerve activity. Mice expressing enhanced green fluorescent protein under control of the promoter for growth hormone secreta-gogue receptor (GHSR) and RT-PCR were used to locate sites of receptor expression. Effects of ghrelin and the nonpeptide GHSR1a agonist capromorelin on rat arteries and on transmission in sympathetic ganglia were measured in vitro. In addition, rat blood pressure and sympathetic nerve activity responses to ghrelin were determined in vivo. In reporter mice, expression of GHSR was revealed at sites where it has been previously demonstrated (hypothalamic neurons, renal tubules, sympathetic preganglionic neurons) but not in any artery studied, including mesenteric, cerebral, and coronary arteries. In rat, RT-PCR detected GHSR1a mRNA expression in spinal cord and kidney but not in the aorta or in mesenteric arteries. Moreover, the aorta and mesenteric arteries from rats were not dilated by ghrelin or capromorelin at concentrations > 100 times their EC50 determined in cells transfected with human or rat GHSR1a. These agonists did not affect transmission from preganglionic sympathetic neurons that express GHSR1a. Intravenous application of ghrelin lowered blood pressure and decreased splanchnic nerve activity. It is concluded that the blood pressure reduction to ghrelin occurs concomitantly with a decrease in sympathetic nerve activity and is not caused by direct actions on blood vessels or by inhibition of transmission in sympathetic ganglia.

AB - Circulating ghrelin reduces blood pressure, but the mechanism for this action is unknown. This study investigated whether ghrelin has direct vasodilator effects mediated through the growth hormone secreta-gogue receptor 1a (GHSR1a) and whether ghrelin reduces sympathetic nerve activity. Mice expressing enhanced green fluorescent protein under control of the promoter for growth hormone secreta-gogue receptor (GHSR) and RT-PCR were used to locate sites of receptor expression. Effects of ghrelin and the nonpeptide GHSR1a agonist capromorelin on rat arteries and on transmission in sympathetic ganglia were measured in vitro. In addition, rat blood pressure and sympathetic nerve activity responses to ghrelin were determined in vivo. In reporter mice, expression of GHSR was revealed at sites where it has been previously demonstrated (hypothalamic neurons, renal tubules, sympathetic preganglionic neurons) but not in any artery studied, including mesenteric, cerebral, and coronary arteries. In rat, RT-PCR detected GHSR1a mRNA expression in spinal cord and kidney but not in the aorta or in mesenteric arteries. Moreover, the aorta and mesenteric arteries from rats were not dilated by ghrelin or capromorelin at concentrations > 100 times their EC50 determined in cells transfected with human or rat GHSR1a. These agonists did not affect transmission from preganglionic sympathetic neurons that express GHSR1a. Intravenous application of ghrelin lowered blood pressure and decreased splanchnic nerve activity. It is concluded that the blood pressure reduction to ghrelin occurs concomitantly with a decrease in sympathetic nerve activity and is not caused by direct actions on blood vessels or by inhibition of transmission in sympathetic ganglia.

KW - Arterial control

KW - Blood pressure

KW - Sympathetic ganglia

UR - http://www.scopus.com/inward/record.url?scp=84867708910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867708910&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00418.2012

DO - 10.1152/ajpheart.00418.2012

M3 - Article

C2 - 22886413

AN - SCOPUS:84867708910

VL - 303

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0002-9513

IS - 8

ER -